Sg Americas Securities, LLC Agios Pharmaceuticals, Inc. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 15,864 shares of AGIO stock, worth $883,307. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,864
Holding current value
$883,307
% of portfolio
0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024
BUY
$41.19 - $49.72 $653,438 - $788,758
15,864 New
15,864 $705,000
Q4 2023

Jan 12, 2024
BUY
$19.97 - $24.53 $7,668 - $9,419
384 Added 1.57%
24,915 $555,000
Q3 2023

Oct 13, 2023
BUY
$24.36 - $28.18 $597,575 - $691,283
24,531 New
24,531 $607,000
Q1 2023

Apr 28, 2023
BUY
$21.74 - $30.93 $35,110 - $49,951
1,615 Added 26.16%
7,789 $179,000
Q4 2022

Feb 02, 2023
SELL
$24.81 - $31.52 $900,999 - $1.14 Million
-36,316 Reduced 85.47%
6,174 $173,000
Q3 2022

Oct 31, 2022
BUY
$19.51 - $34.14 $53,711 - $93,987
2,753 Added 6.93%
42,490 $1.2 Million
Q2 2022

Jul 29, 2022
BUY
$17.06 - $31.42 $370,594 - $682,536
21,723 Added 120.59%
39,737 $881,000
Q1 2022

Apr 29, 2022
SELL
$26.68 - $34.81 $753,683 - $983,347
-28,249 Reduced 61.06%
18,014 $524,000
Q4 2021

Feb 07, 2022
BUY
$29.58 - $49.78 $285,831 - $481,024
9,663 Added 26.4%
46,263 $1.52 Million
Q3 2021

Nov 01, 2021
BUY
$41.92 - $58.18 $1.01 Million - $1.4 Million
24,134 Added 193.6%
36,600 $1.69 Million
Q2 2021

Aug 12, 2021
SELL
$52.06 - $61.27 $66,480 - $78,241
-1,277 Reduced 9.29%
12,466 $687,000
Q1 2021

May 13, 2021
SELL
$44.23 - $57.5 $616,477 - $801,435
-13,938 Reduced 50.35%
13,743 $710,000
Q4 2020

Feb 04, 2021
SELL
$33.21 - $46.54 $116,135 - $162,750
-3,497 Reduced 11.22%
27,681 $1.2 Million
Q3 2020

Nov 09, 2020
BUY
$33.87 - $55.93 $886,987 - $1.46 Million
26,188 Added 524.81%
31,178 $1.09 Million
Q2 2020

Jul 20, 2020
BUY
$34.45 - $53.48 $171,905 - $266,865
4,990 New
4,990 $267,000
Q3 2019

Nov 04, 2019
SELL
$32.4 - $49.58 $130,312 - $199,410
-4,022 Closed
0 $0
Q2 2019

Jul 29, 2019
SELL
$46.17 - $68.1 $1.97 Million - $2.91 Million
-42,697 Reduced 91.39%
4,022 $201,000
Q1 2019

Apr 29, 2019
BUY
$45.92 - $67.67 $1.96 Million - $2.88 Million
42,632 Added 1043.11%
46,719 $3.15 Million
Q4 2018

Feb 01, 2019
BUY
$42.73 - $76.53 $174,637 - $312,778
4,087 New
4,087 $188,000
Q1 2018

May 03, 2018
SELL
$59.83 - $86.53 $205,336 - $296,970
-3,432 Closed
0 $0
Q4 2017

Jan 24, 2018
SELL
$52.12 - $72.33 $218,539 - $303,279
-4,193 Reduced 54.99%
3,432 $196,000
Q3 2017

Nov 07, 2017
BUY
$54.89 - $67.12 $418,536 - $511,790
7,625
7,625 $509,000

Others Institutions Holding AGIO

# of Institutions
232
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.05B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email